These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34726352)

  • 1. The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?
    Peters R; Dodge HH; James S; Jicha GA; Meyer PF; Richards M; Smith AD; Yassine HN; Abner E; Hainsworth AH; Kehoe PG; Beckett N; Anderson CS; Anstey KJ
    Alzheimers Dement; 2022 Mar; 18(3):507-512. PubMed ID: 34726352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
    McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
    Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6.
    Solomon A; Stephen R; Altomare D; Carrera E; Frisoni GB; Kulmala J; Molinuevo JL; Nilsson P; Ngandu T; Ribaldi F; Vellas B; Scheltens P; Kivipelto M;
    Alzheimers Res Ther; 2021 Oct; 13(1):171. PubMed ID: 34635167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors.
    Peters R; Breitner J; James S; Jicha GA; Meyer PF; Richards M; Smith AD; Yassine HN; Abner E; Hainsworth AH; Kehoe PG; Beckett N; Weber C; Anderson C; Anstey KJ; Dodge HH
    Alzheimers Dement (N Y); 2021; 7(1):e12202. PubMed ID: 34934803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the First WHO Guidelines for Risk Reduction of Cognitive Decline and Dementia: Lessons Learned and Future Directions.
    Stephen R; Barbera M; Peters R; Ee N; Zheng L; Lehtisalo J; Kulmala J; Håkansson K; Chowdhary N; Dua T; Solomon A; Anstey KJ; Kivipelto M
    Front Neurol; 2021; 12():763573. PubMed ID: 34764935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerised cognitive training for preventing dementia in people with mild cognitive impairment.
    Gates NJ; Vernooij RW; Di Nisio M; Karim S; March E; Martínez G; Rutjes AW
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012279. PubMed ID: 30864747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific design and effectiveness of non-pharmacological interventions against cognitive decline and dementia-protocol for a systematic review and meta-analysis.
    Zuelke AE; Riedel-Heller SG; Wittmann F; Pabst A; Roehr S; Luppa M
    PLoS One; 2021; 16(8):e0256826. PubMed ID: 34449834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS.
    Rosenberg A; Mangialasche F; Ngandu T; Solomon A; Kivipelto M
    J Prev Alzheimers Dis; 2020; 7(1):29-36. PubMed ID: 32010923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
    Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
    Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidomain interventions for risk reduction and prevention of cognitive decline and dementia: current developments.
    Röhr S; Kivipelto M; Mangialasche F; Ngandu T; Riedel-Heller SG
    Curr Opin Psychiatry; 2022 Jul; 35(4):285-292. PubMed ID: 35703256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial.
    Coley N; Coniasse-Brioude D; Igier V; Fournier T; Poulain JP; Andrieu S;
    Alzheimers Res Ther; 2021 Sep; 13(1):157. PubMed ID: 34560903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidomain trials to prevent dementia: addressing methodological challenges.
    Montero-Odasso M; Zou GY; Kamkar N; Feldman HH; Belleville S; Chertkow H; Nygaard HB; Son S; Speechley M
    Alzheimers Res Ther; 2022 Jul; 14(1):94. PubMed ID: 35820915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review.
    Coley N; Giulioli C; Aisen PS; Vellas B; Andrieu S
    Ageing Res Rev; 2022 Dec; 82():101777. PubMed ID: 36336171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention Matters: Time for Global Action and Effective Implementation.
    Kulmala J; Ngandu T; Kivipelto M
    J Alzheimers Dis; 2018; 64(s1):S191-S198. PubMed ID: 29504541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and memory training in adults at risk of dementia: a systematic review.
    Gates NJ; Sachdev PS; Fiatarone Singh MA; Valenzuela M
    BMC Geriatr; 2011 Sep; 11():55. PubMed ID: 21942932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Modifiable Are Modifiable Dementia Risk Factors? A Framework for Considering the Modifiability of Dementia Risk Factors.
    Bransby L; Rosenich E; Maruff P; Lim YY
    J Prev Alzheimers Dis; 2024; 11(1):22-37. PubMed ID: 38230714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we influence the epidemiology of dementia? Perspectives from population-based studies.
    Birdi R; Stephan BC; Robinson L; Davis D
    Postgrad Med J; 2015 Nov; 91(1081):651-4. PubMed ID: 26324946
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.